Transgenic Core
转基因核心
基本信息
- 批准号:7483083
- 负责人:
- 金额:$ 7.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelArtificial ChromosomesBAC (bacterial artificial chromosome)Bacterial Artificial ChromosomesBos taurusBreedingCattleCellsChimera organismChromosomesChromosomes, Artificial, YeastConsultationsCosmidsCountCryopreservationCultured CellsCustomDNAES Cell LineElectroporationEmbryoEmbryo TransferEnsureEquipmentFacility Construction Funding CategoryFosteringFreezingGene TargetingGenesGeneticGenetically Engineered MouseGenomicsGenotypeHandHuman ResourcesInbred F344 RatsInternetKnockout MiceKnowledgeLaboratory cultureLiquid substanceLiteratureMethodsMicroinjectionsMicromanipulationModificationMolecular BiologyMonitorMothersMouse StrainsMouse, Founder, TransgenicMusMutant Strains MiceMutationNitrogenP1 Bacteriophage Artificial ChromosomesPaperPhenotypePhilosophyPlasmidsProceduresProductionPublishingQuality ControlRattusReagentRecoveryResearchResearch PersonnelResourcesReview LiteratureRheumatismSWR/J MouseSerumServicesSiteSourceStem Cell ResearchTechnologyTestingTimeTrainingTransgenesTransgenic AnimalsTransgenic MiceTransgenic OrganismsWeaningWeekWorkbaseblastocystcostdaydesigndesireeggembryonic stem cellfetalgene functiongerm free conditionhomologous recombinationinnovationinstrumentationinterestmembernew technologypathogenpupquality assurancestemsuccesstransmission processvectorzygote
项目摘要
The Transgenic Core works with investigators to generate animal models that will increase our
fundamental understanding of gene function in rheumatic diseases. This Core was established in 1989 and
produces transgenic mice and rats, and gene-targeted mice (knockouts) for Rheumatic Disease Core Center
members. Other services include rederivation of pathogen free mice, mouse strain cryopreservation and
recovery, and transgenic technology training. The Transgenic Core maintains specialized equipment for
microinjection, cryopreservation, and mouse embryonic stem (ES) cell culture. The Core maintains and
distributes plasmids for transgene or gene targeting vector construction. To maximize gene targeting
success, the Core performs quality assurance tests on ES cell lines, feeder cells, and serum for ES cell
culture. This is a collaborative Core that combines the expertise of investigators in the molecular biology of
the genes they study and the Core's expertise in producing genetically engineered mice.
Unique capabilities that set this Core apart are 1) guaranteed production of transgenic mice and rats, 2)
routine production of BAG transgenic mice, 3) production of transgenic mice in unique genetic backgrounds,
4) gene targeting in C57BL/6 ES cell lines in addition to 129/Sv ES cells, 5) open access to reagents and
equipment, and training in ES cell culture and microinjection methods. Access to the Transgenic Core
obviates the need for investigators to devote resources to equipment purchases and personnel time to
training in micromanipulation, ES cell culture, and mouse embryo manipulation. Consultation on all aspects
of transgenic and ES cell research is provided, from the design of transgenes and conditional targeting
vectors to mouse breeding and phenotype analysis.
We deliver an average of ten transgenic founder mice and guarantee that at least three founders will be
produced for each DMA construct submitted to the Core. The Core electroporates totipotent ES cells with
targeting vectors, selects 480 ES cell clones, and provides investigators with ES cell clone DNA to screen for
homologous recombination with targeting vectors. We guarantee that ES cell clones with desired genetic
changes will be microinjected into at least 50 mouse blastocysts to produce ES cell-mouse chimeras. The
efficiency of these procedures meets or exceeds published values in the literature.
Based on past use, the projected annual usage by Center members is 30 transgenic mouse orders, 6 ES
cell electroporation orders, and 15 ES cell-mouse chimera orders. This is 34% of the Core's total universitywide
capacity and is consistent with past usage by Center Members.
转基因核心与研究人员合作,产生动物模型,将增加我们的
对风湿性疾病中基因功能的基本认识。该中心成立于1989年,
为风湿病核心中心生产转基因小鼠和大鼠,以及基因靶向小鼠(敲除)
成员其他服务包括无病原体小鼠的再衍生、小鼠品系冷冻保存和
康复和转基因技术培训。转基因核心拥有专门的设备,
显微注射、冷冻保存和小鼠胚胎干(ES)细胞培养。核心保持和
分发用于转基因或基因靶向载体构建的质粒。为了最大化基因靶向
成功后,该中心对ES细胞系、饲养细胞和ES细胞血清进行了质量保证试验
文化这是一个合作的核心,结合了研究人员在分子生物学的专业知识,
他们所研究的基因以及核心在生产基因工程小鼠方面的专业知识。
使这个核心与众不同的独特能力是:1)保证生产转基因小鼠和大鼠,2)
BAG转基因小鼠的常规生产,3)独特遗传背景下转基因小鼠的生产,
4)除129/Sv ES细胞外,还在C57 BL/6 ES细胞系中进行基因靶向,5)开放获得试剂,
胚胎干细胞培养和显微注射方法的培训。进入转基因核心
使调查人员无需投入资源购买设备和人员时间,
显微操作、ES细胞培养和小鼠胚胎操作培训。各方面的协商
从转基因设计和条件靶向两个方面介绍了转基因和ES细胞研究的最新进展
载体用于小鼠育种和表型分析。
我们平均提供10只转基因创始小鼠,并保证至少有3只创始小鼠将被
为提交给核心的每个DMA构建体生成。Core电穿孔全能ES细胞,
靶向载体,选择480个ES细胞克隆,并为研究人员提供ES细胞克隆DNA以筛选
与靶向载体的同源重组。我们保证具有所需基因的ES细胞克隆
将这些变化显微注射到至少50个小鼠胚泡中以产生ES细胞-小鼠嵌合体。的
这些方法的效率达到或超过文献中公开的值。
根据过去的使用情况,中心成员预计每年的使用量为30只转基因小鼠订单,6只ES
细胞电穿孔顺序和15个ES细胞-小鼠嵌合体顺序。这是34%的核心的总全校
容量,并与中心成员过去的使用情况一致。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sally A. Camper其他文献
TCF4 is required for normal patterning of FGF and BMP signaling and pituitary anlage specification
- DOI:
10.1016/j.ydbio.2006.04.403 - 发表时间:
2006-07-01 - 期刊:
- 影响因子:
- 作者:
Michelle L. Brinkmeier;Mary Anne Potok;Sally A. Camper - 通讯作者:
Sally A. Camper
Pituitary stem cells: past, present and future perspectives
垂体干细胞:过去、现在和未来展望
- DOI:
10.1038/s41574-023-00922-4 - 发表时间:
2023-12-15 - 期刊:
- 影响因子:40.000
- 作者:
María Inés Pérez Millán;Leonard Y. M. Cheung;Florencia Mercogliano;Maria Andrea Camilletti;Gonzalo T. Chirino Felker;Lucia N. Moro;Santiago Miriuka;Michelle L. Brinkmeier;Sally A. Camper - 通讯作者:
Sally A. Camper
19th International Mouse Genome Conference
- DOI:
10.1007/s00335-005-1900-3 - 发表时间:
2006-05-01 - 期刊:
- 影响因子:2.700
- 作者:
Nicola M. Solomon;Jennifer Dackor;Sally A. Camper - 通讯作者:
Sally A. Camper
Evidence for cell sorting in the pituitary gland
- DOI:
10.1016/j.ydbio.2008.05.425 - 发表时间:
2008-07-15 - 期刊:
- 影响因子:
- 作者:
Shannon W. Davis;Amanda H. Mortensen;Mary A. Potok;Sally A. Camper - 通讯作者:
Sally A. Camper
Wnt genes affect patterning of the ventral diencephalon and pituitary gland growth
- DOI:
10.1016/j.ydbio.2006.04.404 - 发表时间:
2006-07-01 - 期刊:
- 影响因子:
- 作者:
Mary A. Potok;Kelly B. Cha;Andrea Hunt;Michelle L. Brinkmeier;Andreas Kispert;Sally A. Camper - 通讯作者:
Sally A. Camper
Sally A. Camper的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sally A. Camper', 18)}}的其他基金
Discovery Pipeline for Genetic Defects in Hypothalamic-pituitary Development Using International Mouse Phenotyping Consortium Mice
利用国际小鼠表型联盟小鼠发现下丘脑-垂体发育遗传缺陷的管道
- 批准号:
10656660 - 财政年份:2023
- 资助金额:
$ 7.38万 - 项目类别:
High Throughput Functional Assessment SHH Signaling Variants Identified in Patients with Craniofacial Defects and Hypopituitarism
高通量功能评估 在颅面缺陷和垂体机能减退患者中鉴定出 SHH 信号变异
- 批准号:
10285184 - 财政年份:2021
- 资助金额:
$ 7.38万 - 项目类别:
High Throughput Functional Assessment SHH Signaling Variants Identified in Patients with Craniofacial Defects and Hypopituitarism
高通量功能评估 在颅面缺陷和垂体机能减退患者中鉴定出 SHH 信号变异
- 批准号:
10461927 - 财政年份:2021
- 资助金额:
$ 7.38万 - 项目类别:
Hypopituitarism: role of PROP1 and retinoic acid signaling in regulation of pituitary stem cell differentiation
垂体功能减退症:PROP1 和视黄酸信号在垂体干细胞分化调节中的作用
- 批准号:
10596977 - 财政年份:2019
- 资助金额:
$ 7.38万 - 项目类别:
Hypopituitarism: role of PROP1 and retinoic acid signaling in regulation of pituitary stem cell differentiation
垂体功能减退症:PROP1 和视黄酸信号在垂体干细胞分化调节中的作用
- 批准号:
9884806 - 财政年份:2019
- 资助金额:
$ 7.38万 - 项目类别:
Hypopituitarism: role of PROP1 and retinoic acid signaling in regulation of pituitary stem cell differentiation
垂体功能减退症:PROP1 和视黄酸信号在垂体干细胞分化调节中的作用
- 批准号:
10358592 - 财政年份:2019
- 资助金额:
$ 7.38万 - 项目类别:
相似海外基金
CAREER: Characterizing the repeated evolution of dioecy in plants to engineer artificial chromosomes
职业:表征植物中雌雄异株的重复进化,以设计人工染色体
- 批准号:
2239530 - 财政年份:2023
- 资助金额:
$ 7.38万 - 项目类别:
Continuing Grant
Engineering of human artificial chromosomes to decipher the mechanisms of chromosome instability-driven prostate cancer progression
人类人工染色体工程破译染色体不稳定驱动前列腺癌进展的机制
- 批准号:
2827672 - 财政年份:2022
- 资助金额:
$ 7.38万 - 项目类别:
Studentship
Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes
通过真菌人工染色体的发育,快速剖析嗜极真菌共培养中产生的抗 MRSA 抗生素的生物合成
- 批准号:
10546657 - 财政年份:2022
- 资助金额:
$ 7.38万 - 项目类别:
Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes
通过真菌人工染色体的发育,快速剖析嗜极真菌共培养中产生的抗 MRSA 抗生素的生物合成
- 批准号:
10657805 - 财政年份:2022
- 资助金额:
$ 7.38万 - 项目类别:
21ENGBIO Engineering Human Artificial Chromosomes (HACs) to Encode Genome Complexity
21ENGBIO 工程人类人工染色体(HAC)来编码基因组复杂性
- 批准号:
BB/W013169/1 - 财政年份:2022
- 资助金额:
$ 7.38万 - 项目类别:
Research Grant
Construction of artificial chromosomes using silkworm chromosomes with holocentric kinetochores
利用具有全着丝粒着丝粒的家蚕染色体构建人工染色体
- 批准号:
21K05617 - 财政年份:2021
- 资助金额:
$ 7.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of artificial chromosomes for efficient production of omega 3 fatty acids in microalgae
开发人工染色体以在微藻中高效生产 omega 3 脂肪酸
- 批准号:
21K04784 - 财政年份:2021
- 资助金额:
$ 7.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)